South America Brewing Enzymes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The south american brewing enzyme market size was valued at USD 60.57 million in 2025 and estimated to grow from USD 63.72 million in 2026 to reach USD 82.06 million by 2031, at a CAGR of 5.19% during the forecast period (2026-2031). This report is Segmented by Product Type (Amylase, Alphalase, Beta Glucanase, Protease, Other Types), Source (Microbial, Plant), Form (Dry, Liquid), Application (Beer, Wine), and Geography (Brazil, Argentina, Colombia, Chile, Peru, Rest of South America). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Tons).

South America Brewing Enzymes Market Trends and Insights

Rising craft-beer production

By 2023, Brazil's craft-beer segment included 1,847 registered breweries, as stated by the Ministry of Agriculture and Livestock. At the same time, Chile's premium and craft categories are steadily increasing their market share. The growth of small-batch producers has driven up the demand for specific enzymes in specialty styles, such as saisons, sour ales, and hazy IPAs. These styles require precise beta-glucanase and protease dosing to manage viscosity and protein haze, eliminating the need for the expensive filtration systems used by larger breweries. In Colombia, the craft beer market accounts for less than 2 percent of the total market share but is attracting investments from regional private-equity funds. These investors view enzymatic process control as a competitive advantage, particularly in a market where Bavaria dominates with 98 percent of the mainstream volume. In Argentina, brewers are taking advantage of increased domestic barley production, spurred by European buyers seeking alternatives to Russian and Ukrainian supplies, to explore single-origin malt profiles. They are using amylase blends to extract fermentable sugars from grains with lower diastatic power. The growing craft-beer movement is driving demand for liquid enzyme formats, which dissolve quickly and enable easier dosing in batches ranging from 500 to 5,000 liters. However, dry enzymes are also gaining popularity among larger regional players looking to reduce their dependence on cold-chain logistics.

Growing demand for low-/no-alcohol beer styles

In Brazil, non-alcoholic beer consumption has risen significantly, driven by growing health awareness and stricter drunk-driving regulations. According to Banco do Nordeste, Brazil's annual consumption of non-alcoholic beverages reached 21.63 billion liters in 2024. Brewers are increasingly using enzymatic production methods, particularly controlled applications of amylase and glucoamylase. This approach halts fermentation at or below 0.5% alcohol by volume, preserving malt sweetness and body, attributes often diminished by thermal dealcoholization or reverse-osmosis techniques. Similarly, Chile's premium beer segment is implementing these enzyme-based methods to introduce low-alcohol product lines that appeal to female consumers and younger audiences seeking moderation without compromising flavor. However, balancing residual maltose and dextrin profiles presents a technical challenge. Excessive amylase activity can result in a thin, watery mouthfeel, while insufficient conversion leaves an overly sweet taste. To address this, enzyme suppliers are developing time-temperature-optimized blends that achieve a final gravity of 4 to 6 Plato. In Argentina, brewers are incorporating proteases to improve foam stability in low-alcohol variants, offsetting the reduced role of ethanol in bubble formation and head retention. These advancements are driving the adoption of plant-based enzymes like papain, valued for their broader pH tolerance and compatibility with clean-label trends, which resonate strongly in health-focused retail markets.

Fragmented cold-chain logistics for liquids

Brazil's refrigerated-storage infrastructure fails to meet growing demand. Consequently, liquid-enzyme distributors depend on third-party cold-chain providers, whose energy expenses account for 75 percent of operating budgets. Liquid enzymes must be stored at temperatures between 2 to 8 degrees Celsius to preserve their activity over a six-to-twelve-month shelf life. However, temperature fluctuations during inland transport, particularly to breweries in Brazil's Northeast or Colombia's Andean regions, can reduce enzyme potency by 10 to 15 percent. This loss forces brewers to over-order by 20 percent to mitigate activity degradation. In Colombia, logistics costs are inflated by inadequate road infrastructure and complex regulatory checkpoints. INVIMA, the regulatory authority, requires Good Manufacturing Practice certification and Spanish-language labeling. Furthermore, customs clearance at Bogotá and Cartagena ports can extend lead times by two to three weeks. This fragmented system is driving brewers to adopt dry enzyme formats, which can be stored at ambient temperatures and have a shelf life of two to three years. However, these formats come with drawbacks, such as longer dissolution times and dust-handling challenges in manual-dosing environments. This issue is particularly severe for small craft breweries without on-site refrigeration. They must either accept a shorter enzyme shelf life or pay a 15 to 20 percent premium for dry formulations.

Other drivers and restraints analyzed in the detailed report include:

• Increasing adoption of enzymes in high gravity brewing
• Flavor innovation through controlled enzymatic conversion
• Currency-linked import duties on specialty enzymes

Segment Analysis

In 2025, amylase contributes 39.12 percent of product-type revenue, highlighting its essential role in starch liquefaction and saccharification across brewing processes, including lagers, ales, and adjunct-heavy protocols. Beta-glucanase, growing at a 5.63 percent CAGR through 2031, is driven by craft brewers increasingly incorporating oat, wheat, and barley. These grains elevate wort beta-glucan content beyond 200 milligrams per liter, necessitating enzymatic solutions to prevent filtration blockages and haze formation. Protease, which holds a notable share, helps brewers reduce chill-haze precursors and accelerate conditioning cycles. This is particularly important for fast-turnaround lagers, with Brazilian and Colombian breweries now adopting 14-day fermentation windows as a standard.

Additionally, enzymes such as xylanase, cellulase, and acetolactate decarboxylase serve niche purposes in gluten-reduced beer production and diacetyl management. Their adoption is primarily seen in premium and craft segments, where consumers are willing to pay a 10 to 15 percent premium for distinctive flavor profiles. This product-type segmentation reflects a maturing market: foundational enzymes like amylase and protease continue to sustain volume, while specialty enzymes such as beta-glucanase and xylanase drive margin growth and enable brewers to achieve premium retail pricing.

In 2025, microbial enzymes account for 81.2 percent of source-based revenue. This dominance is driven by the consistent activity and scalable fermentation economics of Aspergillus and Bacillus strains, which have also gained regulatory approvals from Brazil's ANVISA, Argentina's ANMAT, and Colombia's INVIMA. Meanwhile, plant-based enzymes are projected to grow at a 5.74 percent CAGR through 2031. This growth is supported by increasing consumer demand for clean-label products and craft brewers' efforts to avoid Brazil's CTNBio labeling requirements for genetically modified organisms. Enzymes such as papain, bromelain, and ficin, extracted from papaya, pineapple, and fig, offer a broader pH tolerance (3.5 to 8.0) compared to microbial amylase (pH 5.0 to 6.5). Their non-GMO positioning appeals to organic-certified and export-oriented brewing segments. While Argentina's CONABIA regulates GMO enzyme approvals and provides a clear pathway, some microbreweries prefer plant-derived enzymes to mitigate consumer concerns in Buenos Aires and Córdoba, where allergen-related narratives are gaining traction.

The cost difference remains significant, as plant-based enzymes are priced higher than microbial alternatives due to lower fermentation yields and the seasonal availability of raw materials. However, premium and craft brewers are willing to absorb these costs to enhance their marketing claims around natural ingredients and biodiversity sourcing. In Chile, the adoption of plant-based enzymes is accelerating in wine production. Pectinase and cellulase, derived from fungal or plant sources, are used to clarify grape must without introducing microbial off-flavors, preserving the varietal character of Malbec or Carmenere blends. On the innovation front, Brazil's CNPEM has discovered the CelOCE enzyme from the country's biodiversity. With patenting in progress and licensing discussions expected to conclude within one to four years, this development could reduce plant-based enzyme costs by 10 to 12 percent if scaled for commercial fermentation. This source segmentation highlights a strategic contrast: microbial enzymes lead in cost-performance, while plant-based enzymes are gaining traction due to their alignment with sustainability and clean-label trends that are reshaping purchasing decisions in the premium segment.

Complete Report Scope:

• By Product Type
  • Amylase
  • Alphalase
  • Beta Glucanase
  • Protease
  • Other Types
• By Source
  • Microbial
  • Plant
• By Form
  • Dry
  • Liquid
• By Application
  • Beer
  • Wine
• By Country
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America

List of Companies Covered in this Report:

• Novonesis
• DSM-Firmenich.
• DuPont de Nemours, Inc.
• Associated British Foods plc (AB Enzymes)
• Merck KGaA
• Kerry Group plc
• The Soufflet Group
• BASF SE
• Amano Enzyme Inc.
• Advanced Enzyme Technologies Ltd.
• Aum Enzymes
• Prozyn Industria e Comercio S/A
• Chr. Hansen Holding A/S
• Dyadic International, Inc.
• IFF (Danisco)
• BioCatalysts Ltd.
• Enzyme Innovation
• Angel Yeast Co., Ltd.
• Megazyme Ltd.
• Antozyme Biotech Pvt Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support